X-ZELL CEO to speak at Bio Pitch & Partner Conference
Based in Bangkok, Thailand, and Sunnyvale, California, X-ZELL is a Silicon Valley backed start-up specialising in early cancer detection that is about to go live with a revolutionary, non-invasive prostate cancer test capable of identifying Circulating Endothelial Cells (CEC) in a simple blood sample.
Dr Bhakdi will use his keynote speech to give the audience an exclusive ‘behind the scenes’ tour of X-ZELL Inc. and reflect on the long and testing journey that saw a one-man start-up grow into a globally positioned enterprise with a game- changing future vision.
He will also give a sneak peek at the world’s first CEC breast cancer study designed in collaboration with Dr Pornchai O-Charoenrat, Chief of the Department of Head, Neck and Breast Surgery at Mahidol University’s Siriraj Hospital in Bangkok, as well as a 1,000 patient study backed by the Thailand Research Fund (TRF).
Thailand LAB 2017 will be held from 6-8 September 2017 at the Bangkok International Trade & Exhibition Centre (BITEC).
Dr Bhakdi’s keynote speech will be part of the two-day Bio Pitch & Partner Conference and take place on 7 September at 10:30am in Conference Room A. He will be available for a limited number of media interviews following his presentation. Please register your interest as per contact below.
Media Contact:
Sebastian Grote
Head of Marketing & Communications
+61 425 699 879 (AUS & Global)
+66 6 2197 8788 (THA)
sebastian.g@x-zell.com
www.x-zell.com
X-ZELL
FIGHTING CANCER,
ONE CELL AT A TIME.
© 2022 X-ZELL INC
Explore
Find Us